Suppr超能文献

水飞蓟素通过包封于新型囊泡纳米系统双分子层脂质体中而增强的肝脏保护活性。

Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes.

作者信息

Mohsen Amira Mohamed, Asfour Marwa Hasanein, Salama Abeer A A

机构信息

a Pharmaceutical Technology Department , National Research Centre , Dokki , Egypt.

b Pharmacology Department , National Research Centre , Dokki , Egypt.

出版信息

Drug Dev Ind Pharm. 2017 Dec;43(12):2043-2054. doi: 10.1080/03639045.2017.1361968. Epub 2017 Aug 13.

Abstract

The main objective of the present work was to formulate, characterize, and evaluate silymarin (SM)-loaded bilosomes, compared to conventional liposomes, aiming at increasing the hepatoprotective activity of the drug. SM-loaded bilosomes were prepared by thin film hydration technique employing soybean phosphatidyl choline (SPC) and different bile salts. After being subjected to different methods of characterization, SM-loaded bilosomes were investigated for their hepatoprotective activity, in CCl hepatointoxicated rat model. The developed SM dispersions exhibited an entrapment efficiency ranging from 21.80 ± 2.01 to 84.54 ± 2.51% and a particle size diameter in the nanometric dimensions (413 ± 96.9 to 686.9 ± 62.38 nm), with a negative zeta potential values (<-45 mV). In vitro release study revealed a lower cumulative amount of drug released from the developed formulae, compared to free drug. Ex vivo intestinal uptake study, performed using confocal laser scanning calorimetry, revealed the superiority of bilosomal uptake compared to that of liposomes. In vivo studies revealed an enhanced hepatoprotective effect of SM-loaded bilosomes/liposomes compared to free drug. These results were in good correlation with histopathological examination. These findings support the potential use of bilosomes for improving the hepatoprotective activity of SM via oral administration.

摘要

本研究的主要目的是制备、表征和评估与传统脂质体相比的水飞蓟素(SM)负载双分子层脂质体,旨在提高该药物的肝保护活性。采用大豆磷脂酰胆碱(SPC)和不同的胆盐,通过薄膜水化技术制备了负载SM的双分子层脂质体。在进行了不同的表征方法后,在四氯化碳肝中毒大鼠模型中研究了负载SM的双分子层脂质体的肝保护活性。所制备的SM分散体的包封率在21.80±2.01%至84.54±2.51%之间,粒径在纳米尺寸范围内(413±96.9至686.9±62.38nm),zeta电位为负值(<-45mV)。体外释放研究表明,与游离药物相比,所制备配方中释放的药物累积量较低。使用共聚焦激光扫描量热法进行的离体肠道摄取研究表明,双分子层脂质体的摄取优于脂质体。体内研究表明,与游离药物相比,负载SM的双分子层脂质体/脂质体具有增强的肝保护作用。这些结果与组织病理学检查结果高度相关。这些发现支持了双分子层脂质体通过口服给药提高SM肝保护活性的潜在用途。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验